Methamphetamine

Methamphetamine
Name	Methamphetamine
Alt	Structural formula of methamphetamine
Tradenames	Desoxyn
Routes of administration	Oral; intranasal; intravenous; inhalation; rectal
Legal status	Varies by country
Chemical formula	C10H15N
Molar mass	149.24 g·mol−1

Methamphetamine is a central nervous system stimulant belonging to the phenethylamine and amphetamine chemical classes. First synthesized in the late 19th century, it gained medical, military, and illicit significance through the 20th and 21st centuries, intersecting with figures and institutions such as Otto Diels, Albert Hofmann, World War II, United States Armed Forces, and Drug Enforcement Administration. Its pharmacology, public health impact, and legal regulation involve interactions with entities like Food and Drug Administration, World Health Organization, United Nations Office on Drugs and Crime, and numerous national legislatures.

Chemistry and Pharmacology

Methamphetamine is an N-methylated derivative of amphetamine with the chemical formula C10H15N and a chiral center producing dextro- and levo- enantiomers; the dextro form is more centrally active. Its synthesis and stereochemistry were elucidated in chemistry laboratories associated with figures such as Eugen Baumann and institutions like University of Berlin and University of Basel. Pharmacodynamically, methamphetamine increases synaptic concentrations of monoamines by interacting with vesicular monoamine transporter 2 in pathways involving dopamine, norepinephrine, and serotonin circuits linked to brain regions studied at centers such as National Institutes of Health and Harvard Medical School. Receptor-level and transporter interactions have been characterized in research from laboratories at Cold Spring Harbor Laboratory, Max Planck Society, and Scripps Research, involving proteins like the dopamine transporter and trace amine-associated receptor 1. Metabolism principally occurs via hepatic enzymes including cytochrome P450 isoforms studied at Mayo Clinic and Johns Hopkins University, producing metabolites such as amphetamine and p-hydroxymethamphetamine.

Medical Uses and Treatment

Medically, pharmaceutical formulations have been approved under brand names produced by companies regulated by the Food and Drug Administration and overseen by agencies like Health Canada and European Medicines Agency. Indications historically included attention-deficit hyperactivity disorder and treatment-resistant obesity; contemporary clinical practice and guidelines from institutions such as American Psychiatric Association and National Institute for Health and Care Excellence favor alternative agents, with restricted use under programs like prescription monitoring systems implemented in states such as California and Texas. Treatment of methamphetamine use disorder employs psychosocial interventions developed by researchers at Columbia University, University of California, Los Angeles, and Yale University—including cognitive-behavioral therapy and contingency management models pioneered with support from foundations such as the Robert Wood Johnson Foundation. Pharmacotherapy research has involved trials of medications investigated at centers like Vanderbilt University and University of Pennsylvania.

Recreational Use and Epidemiology

Recreational use emerged prominently in eras linked to events such as World War II stimulant campaigns and postwar trafficking networks involving routes through regions including Southeast Asia, Mexico, and United States. Epidemiological surveillance by Centers for Disease Control and Prevention, Australian Institute of Health and Welfare, and European Monitoring Centre for Drugs and Drug Addiction tracks prevalence, which varies across populations studied in metropolitan areas like Los Angeles, Tokyo, Sydney, and Vancouver. Patterns of consumption have been influenced by social phenomena examined in studies from University of Oxford and University of Cambridge, with harm-reduction programs evaluated in contexts involving organizations such as Médecins Sans Frontières and Harm Reduction International.

Health Effects and Toxicity

Acute effects include sympathomimetic stimulation with cardiovascular impacts documented in case series reported by hospitals affiliated with Massachusetts General Hospital and Mount Sinai Health System. Chronic use is associated with neuropsychiatric sequelae including psychosis and cognitive impairment investigated by neuroscientists at University College London, King's College London, and University of Toronto. Toxicology profiles, overdose management, and emergency protocols have been developed by bodies such as American College of Emergency Physicians and European Resuscitation Council. Complications include infectious disease risks studied in cohorts by Johns Hopkins Bloomberg School of Public Health and dental morbidity characterized in clinical reports from University of Michigan.

Legal Status and Regulation

National and international control measures classify methamphetamine under schedules administered by organizations including the United Nations Commission on Narcotic Drugs and national agencies such as the Drug Enforcement Administration, Health Canada, and Australian Department of Health. Policy responses have ranged from criminal enforcement by law-enforcement bodies like Royal Canadian Mounted Police and Mexican Federal Police to public-health approaches advocated by World Health Organization and nongovernmental organizations such as Open Society Foundations. Legislative instruments influencing availability include statutes enacted by parliaments in countries such as United Kingdom, Japan, Brazil, and Germany, while courts at levels including Supreme Court of the United States have adjudicated enforcement and sentencing issues.

Detection, Synthesis, and Illicit Production

Analytical detection employs techniques developed in laboratories at institutions like National Institute of Standards and Technology, Federal Bureau of Investigation forensic labs, and university centers using gas chromatography–mass spectrometry, liquid chromatography–tandem mass spectrometry, and immunoassays. Legal synthetic routes were described in chemical literature from universities such as University of Vienna and Massachusetts Institute of Technology, while clandestine production has been documented in investigations by agencies including Drug Enforcement Administration and Mexican Navy. Supply-chain interdiction operations have involved multinational cooperation coordinated through mechanisms like Interpol and bilateral task forces between nations such as United States and Mexico.

Category:Stimulants